Kazia Therapeutics Ltd (KZIA) ADR Each Representing 500 Ord Shares SPON

Sell:$11.00Buy:$12.06Price increased$1.29 (12.60%)

Prices delayed by at least 15 minutes
Sell:$11.00
Buy:$12.06
Change:Price increased$1.29 (12.60%)
Deal now
Prices delayed by at least 15 minutes
Sell:$11.00
Buy:$12.06
Change:Price increased$1.29 (12.60%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$10.50
Previous close$10.24
Market cap$112.58m
P/E ratio-
Volume1,079,232
Dividend yield0.00%
EMS-

Company information

Kazia Therapeutics Limited is an Australia-based pharmaceutical drug development company. The Company operates in the pharmaceutical research and development business. The Company’s lead program is paxalisib, an ...

  • LocationAustralia
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue4.56m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.